11/20/2024
10:15 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/18/2024
5:11 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/15/2024
8:13 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/15/2024
5:48 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/13/2024
11:31 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/12/2024
6:10 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/08/2024
8:10 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
|
11/01/2024
10:46 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/30/2024
8:38 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/28/2024
5:00 AM | ASTRAZENECA PLC (Filed by)
AstraZeneca (Filed by)
Monopar Therapeutics (Subject)
| Form SC 13G | |
10/21/2024
8:48 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/11/2024
5:01 AM | ASTRAZENECA PLC (Filed by)
AstraZeneca (Filed by)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
| Form SC 13G | |
10/07/2024
5:38 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/01/2024
9:45 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/26/2024
5:42 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/23/2024
5:44 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/23/2024
5:27 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/20/2024
12:34 PM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/18/2024
5:21 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/13/2024
9:50 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/03/2024
5:05 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/16/2024
5:21 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/01/2024
9:11 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/30/2024
5:26 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/29/2024
5:00 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/26/2024
5:42 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/25/2024
8:06 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/15/2024
5:15 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/01/2024
9:07 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/01/2024
5:07 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/26/2024
4:00 PM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
06/25/2024
5:12 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/25/2024
5:07 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/18/2024
5:38 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/17/2024
5:21 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/12/2024
9:14 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/04/2024
9:02 AM | ASTRAZENECA PLC (Subject)
AstraZeneca (Subject)
Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE | |
06/03/2024
9:23 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/03/2024
9:29 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/03/2024
5:35 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/28/2024
5:15 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad) As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential.
Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention. 👉 Click here to access your FREE report now! |
05/21/2024
5:08 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/20/2024
5:32 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/16/2024
5:41 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/15/2024
9:09 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/07/2024
6:31 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/02/2024
5:49 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/29/2024
6:18 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/29/2024
5:52 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/25/2024
5:26 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/11/2024
12:22 PM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/11/2024
5:55 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/08/2024
5:14 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/08/2024
5:14 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/05/2024
5:22 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/02/2024
7:45 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/02/2024
6:54 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/25/2024
6:28 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/19/2024
4:27 PM | ASTRAZENECA PLC (Filed by)
AstraZeneca (Filed by)
Fusion Pharmaceuticals Inc. (Subject)
| Form DFAN14A | |
03/19/2024
3:31 PM | AstraZeneca Finance LLC (Filer)
ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form F-3ASR | |
03/19/2024
5:02 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/14/2024
6:12 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/12/2024
6:29 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/07/2024
5:30 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/07/2024
5:34 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/06/2024
9:06 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/06/2024
9:11 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/06/2024
6:21 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form CERT | |
03/05/2024
3:40 PM | AstraZeneca Finance LLC (Filer)
ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 8-A12B | |
03/04/2024
5:33 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/01/2024
9:39 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/26/2024
5:19 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/22/2024
8:14 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/22/2024
8:19 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/22/2024
5:08 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/21/2024
7:32 AM | ASTRAZENECA PLC (Filed by)
AstraZeneca (Filed by)
Icosavax, Inc. (Subject)
| Form SC TO-T/A | |
02/21/2024
7:13 AM | AstraZeneca Finance LLC (Filer)
ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 424B2
Transaction specifc information for a delayed shelf offering | |
02/21/2024
5:04 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/20/2024
8:25 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/20/2024
6:51 AM | ASTRAZENECA PLC (Filed by)
AstraZeneca (Filed by)
Icosavax, Inc. (Subject)
| Form SC TO-T/A | |
02/20/2024
6:49 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/20/2024
6:12 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/20/2024
5:52 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/20/2024
5:47 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/20/2024
5:27 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/12/2024
9:13 AM | ADC Therapeutics SA (Subject)
ASTRAZENECA PLC (Filed by)
AstraZeneca (Filed by)
| Form SC 13G/A | |
02/08/2024
5:40 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/01/2024
9:30 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/24/2024
4:23 PM | ASTRAZENECA PLC (Subject)
AstraZeneca (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
01/19/2024
7:46 AM | ASTRAZENECA PLC (Filed by)
AstraZeneca (Filed by)
Icosavax, Inc. (Subject)
| Form SC TO-T/A | |
01/19/2024
7:31 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad) As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential.
Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention. 👉 Click here to access your FREE report now! |
01/10/2024
7:39 PM | ASTRAZENECA PLC (Filed by)
AstraZeneca (Filed by)
Icosavax, Inc. (Subject)
| Form SC TO-T/A | |
01/02/2024
9:53 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/27/2023
7:03 AM | ASTRAZENECA PLC (Filed by)
AstraZeneca (Filed by)
Icosavax, Inc. (Subject)
| Form SC TO-T | |
12/27/2023
6:09 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/26/2023
4:25 PM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/22/2023
5:19 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/14/2023
9:20 AM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/12/2023
4:15 PM | ASTRAZENECA PLC (Filer)
AstraZeneca (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/12/2023
4:15 PM | ASTRAZENECA PLC (Filed by)
AstraZeneca (Filed by)
Icosavax, Inc. (Subject)
| Form SC TO-C | |
